SCAIL-1 identifies the key bottlenecks that hinder character animation towards production level: how to represent the pose and how to inject the pose. However, the reliance on intermediate pose ...

Encryption systems rely on “random” numbers, but conventional computers can’t generate them perfectly. New research shows that quantum physics can. By Alexander Nazaryan Researchers in Switzerland ...

Alibaba wants you to compare its new AI video generator to OpenAI's Sora. Otherwise, why use it to make Sora's most famous creation belt out a Dua Lipa song? On Tuesday, an organization called the ...

Writing from the Chicagoland area in Illinois, Robert is an avid movie watcher and will take just about any excuse to find time to go to his local movie theaters. Robert graduated from Bradley ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Sony’s Venom franchise has a new final destination. The studio behind the Marvel anti-hero movies is developing its first animated movie based on the character. And it has tapped Zach Lipovsky and ...

More than 100 years ago Hungarian-born mathematician George Pólya found himself trapped in a loop of social awkwardness. A professor at the Swiss Federal Institute of Technology Zurich, he enjoyed ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...